Corrigendum: Abscopal Effects in Radio-Immunotherapy—Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2020-01-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01615/full |
| _version_ | 1818849612301074432 |
|---|---|
| author | Maike Trommer Maike Trommer Maike Trommer Sin Yuin Yeo Sin Yuin Yeo Thorsten Persigehl Thorsten Persigehl Anne Bunck Anne Bunck Holger Grüll Holger Grüll Max Schlaak Max Schlaak Sebastian Theurich Sebastian Theurich Sebastian Theurich Michael von Bergwelt-Baildon Michael von Bergwelt-Baildon Janis Morgenthaler Janis Morgenthaler Jan M. Herter Jan M. Herter Jan M. Herter Eren Celik Eren Celik Simone Marnitz Simone Marnitz Simone Marnitz Christian Baues Christian Baues Christian Baues |
| author_facet | Maike Trommer Maike Trommer Maike Trommer Sin Yuin Yeo Sin Yuin Yeo Thorsten Persigehl Thorsten Persigehl Anne Bunck Anne Bunck Holger Grüll Holger Grüll Max Schlaak Max Schlaak Sebastian Theurich Sebastian Theurich Sebastian Theurich Michael von Bergwelt-Baildon Michael von Bergwelt-Baildon Janis Morgenthaler Janis Morgenthaler Jan M. Herter Jan M. Herter Jan M. Herter Eren Celik Eren Celik Simone Marnitz Simone Marnitz Simone Marnitz Christian Baues Christian Baues Christian Baues |
| author_sort | Maike Trommer |
| collection | DOAJ |
| first_indexed | 2024-12-19T06:36:00Z |
| format | Article |
| id | doaj.art-768197cd9ce34d2cbb6368b793e4d72c |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-12-19T06:36:00Z |
| publishDate | 2020-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-768197cd9ce34d2cbb6368b793e4d72c2022-12-21T20:32:14ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-01-011010.3389/fphar.2019.01615515646Corrigendum: Abscopal Effects in Radio-Immunotherapy—Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint InhibitionMaike Trommer0Maike Trommer1Maike Trommer2Sin Yuin Yeo3Sin Yuin Yeo4Thorsten Persigehl5Thorsten Persigehl6Anne Bunck7Anne Bunck8Holger Grüll9Holger Grüll10Max Schlaak11Max Schlaak12Sebastian Theurich13Sebastian Theurich14Sebastian Theurich15Michael von Bergwelt-Baildon16Michael von Bergwelt-Baildon17Janis Morgenthaler18Janis Morgenthaler19Jan M. Herter20Jan M. Herter21Jan M. Herter22Eren Celik23Eren Celik24Simone Marnitz25Simone Marnitz26Simone Marnitz27Christian Baues28Christian Baues29Christian Baues30Faculty of Medicine and University Hospital Cologne, Department of Radiation Oncology and Cyberknife Center, University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Department of Diagnostic and Interventional Radiology, University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Department of Diagnostic and Interventional Radiology, University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Department of Diagnostic and Interventional Radiology, University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Department of Diagnostic and Interventional Radiology, University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, GermanyDepartment of Dermatology and Allergology, Ludwig-Maximilians University Munich, Munich, GermanyFaculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, GermanyDepartment of Medicine III, University Hospital, Ludwig-Maximilians University Munich, Munich, GermanyGene Center, Cancer- and Immunometabolism Research Group, Ludwig-Maximilians University Munich, Munich, GermanyFaculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, GermanyDepartment of Medicine III, University Hospital, Ludwig-Maximilians University Munich, Munich, GermanyFaculty of Medicine and University Hospital Cologne, Department of Radiation Oncology and Cyberknife Center, University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Department of Radiation Oncology and Cyberknife Center, University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne, University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Department of Radiation Oncology and Cyberknife Center, University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Department of Radiation Oncology and Cyberknife Center, University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Department of Radiation Oncology and Cyberknife Center, University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, GermanyFaculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, Germanyhttps://www.frontiersin.org/article/10.3389/fphar.2019.01615/fullabscopal effectPD-1radio-immunotherapyradiotherapycombination treatmentadvanced cancer disease |
| spellingShingle | Maike Trommer Maike Trommer Maike Trommer Sin Yuin Yeo Sin Yuin Yeo Thorsten Persigehl Thorsten Persigehl Anne Bunck Anne Bunck Holger Grüll Holger Grüll Max Schlaak Max Schlaak Sebastian Theurich Sebastian Theurich Sebastian Theurich Michael von Bergwelt-Baildon Michael von Bergwelt-Baildon Janis Morgenthaler Janis Morgenthaler Jan M. Herter Jan M. Herter Jan M. Herter Eren Celik Eren Celik Simone Marnitz Simone Marnitz Simone Marnitz Christian Baues Christian Baues Christian Baues Corrigendum: Abscopal Effects in Radio-Immunotherapy—Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition Frontiers in Pharmacology abscopal effect PD-1 radio-immunotherapy radiotherapy combination treatment advanced cancer disease |
| title | Corrigendum: Abscopal Effects in Radio-Immunotherapy—Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition |
| title_full | Corrigendum: Abscopal Effects in Radio-Immunotherapy—Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition |
| title_fullStr | Corrigendum: Abscopal Effects in Radio-Immunotherapy—Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition |
| title_full_unstemmed | Corrigendum: Abscopal Effects in Radio-Immunotherapy—Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition |
| title_short | Corrigendum: Abscopal Effects in Radio-Immunotherapy—Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition |
| title_sort | corrigendum abscopal effects in radio immunotherapy response analysis of metastatic cancer patients with progressive disease under anti pd 1 immune checkpoint inhibition |
| topic | abscopal effect PD-1 radio-immunotherapy radiotherapy combination treatment advanced cancer disease |
| url | https://www.frontiersin.org/article/10.3389/fphar.2019.01615/full |
| work_keys_str_mv | AT maiketrommer corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT maiketrommer corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT maiketrommer corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT sinyuinyeo corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT sinyuinyeo corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT thorstenpersigehl corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT thorstenpersigehl corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT annebunck corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT annebunck corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT holgergrull corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT holgergrull corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT maxschlaak corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT maxschlaak corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT sebastiantheurich corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT sebastiantheurich corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT sebastiantheurich corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT michaelvonbergweltbaildon corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT michaelvonbergweltbaildon corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT janismorgenthaler corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT janismorgenthaler corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT janmherter corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT janmherter corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT janmherter corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT erencelik corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT erencelik corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT simonemarnitz corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT simonemarnitz corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT simonemarnitz corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT christianbaues corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT christianbaues corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition AT christianbaues corrigendumabscopaleffectsinradioimmunotherapyresponseanalysisofmetastaticcancerpatientswithprogressivediseaseunderantipd1immunecheckpointinhibition |